Table 2.

Total BoNT-A dosages injected per upper limb for each participant over the three injection treatments.

Patient	Total Arm Dose
	Week 0 (1st Injection) (N = 31)		Week 12 (2nd Injection) (N = 29)		Week 24 (3rd Injection) (N = 23)
	Motor Dominant	Non-Motor Dominant	Motor Dominant	Non-Motor Dominant	Motor Dominant	Non-Motor Dominant
1	160	100	225	160	270	205
2	190	160	190	225	190	235
3	190	120	180	110	No injection (a)
4	175	215	170	150	No injection (c)
5	100	119	105	140	No injection (c)
6	270	300	195	215	185	205
7	160	105	No injection (a)
8	90	60	155	105	150	70
9	60	60	60	60	60	60
10	180	260	180	300	180	300
11	100	110	100	110	100	110
12	100	100	130	135	130	135
13	70	110	No injection (b)
14	200	125	200	125	185	125
15	195	155	195	155	195	155
16	100	55	100	55	100	55
17	140	110	195	110	205	140
18	100	145	125	180	135	210
19	100	120	200	210	230	240
20	120	175	120	175	130	185
21	120	100	145	100	145	100
22	150	120	100	155	No injection (a)
23	120	175	165	240	160	235
24	155	140	155	170	No injection (c)
25	145	30	155	30	155	45
26	180	100	210	110	No injection (d)
27	100	120	100	145	100	135
28	115	115	140	140	90	90
29	240	200	165	165	165	165
30	35	20	35	20	35	20
31	60	40	65	85	65	110
Mean	136.1	124.6	146.9	140.7	146.1	144.8
SD	54.1	61.8	48.9	62.2	57.0	73.1
Range	20–100	20–120	30–90	30–80	40–100	35–100

^a Other health concerns ^b Pregnancy ^c Limited perceived benefit and/or arm muscle weakness ^d Travel concerns.